Outcomes in Patients With Heart Failure Association of Serum Digoxin Concentration and

[1]  Harlan M Krumholz,et al.  Sex-based differences in the effect of digoxin for the treatment of heart failure. , 2002, The New England journal of medicine.

[2]  B. G. Krohn.  Controlling the effectiveness of digoxin. , 2002, Journal of the American College of Cardiology.

[3]  J. H. Patterson,et al.  Clinical benefits of low serum digoxin concentrations in heart failure. , 2002, Journal of the American College of Cardiology.

[4]  S. Yusuf,et al.  The 2001 Canadian Cardiovascular Society consensus guideline update for the management and prevention of heart failure. , 2001, The Canadian journal of cardiology.

[5]  P. Rahko,et al.  Low-dose enoximone improves exercise capacity in chronic heart failure. Enoximone Study Group. , 2000, Journal of the American College of Cardiology.

[6]  C. Gibbs,et al.  ABC of heart failure: Management: digoxin and other inotropes, ß blockers, and antiarrhythmic and antithrombotic treatment , 2000, BMJ.

[7]  W. Gattis,et al.  Therapeutic Range of Digoxin's Efficacy in Heart Failure: What Is the Evidence? , 1999, Pharmacotherapy.

[8]  D. DeMets,et al.  A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure , 1998 .

[9]  S. Zoneraich.  Digoxin in patients with heart failure. , 1997, The New England journal of medicine.

[10]  M. Gheorghiade,et al.  Digitalis Investigation Group (DIG) trial: a stimulus for further research. , 1997, American heart journal.

[11]  P. Grayburn,et al.  Does digoxin provide additional hemodynamic and autonomic benefit at higher doses in patients with mild to moderate heart failure and normal sinus rhythm? , 1997, Journal of the American College of Cardiology.

[12]  D. M. Barr,et al.  Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. , 1996, Controlled clinical trials.

[13]  U. Goldbourt,et al.  Digoxin and increased mortality among patients recovering from acute myocardial infarction: Importance of digoxin dose , 1995, Cardiovascular Drugs and Therapy.

[14]  W. Remme.  Inotropic agents for heart failure: what if digoxin increases mortality? , 1994, British heart journal.

[15]  P. Royston,et al.  Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling. , 1994 .

[16]  M. Bristow,et al.  Low-dose inotropic therapy for ambulatory heart failure. , 1994, Coronary artery disease.

[17]  J. McMurray,et al.  Fortnightly Review: Diagnosis and management of heart failure , 1994, BMJ.

[18]  J. Brouwer,et al.  Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). , 1993, Journal of the American College of Cardiology.

[19]  M. Packer,et al.  The development of positive inotropic agents for chronic heart failure: how have we gone astray? , 1993, Journal of the American College of Cardiology.

[20]  M. Packer.  The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. , 1992, Journal of the American College of Cardiology.

[21]  D. Ferguson,et al.  Digoxin. A neurohormonal modulator in heart failure? , 1991, Circulation.

[22]  R. Luchi,et al.  Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure , 1984, Journal of the American Geriatrics Society.

[23]  R. Jelliffe,et al.  A nomogram for digoxin therapy. , 1974, American Journal of Medicine.

[24]  D. V. van Veldhuisen.  Low-dose digoxin in patients with heart failure. Less toxic and at least as effective? , 2002, Journal of the American College of Cardiology.

[25]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[26]  S. Goldsmith.  Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. , 1997, Journal of the American College of Cardiology.

[27]  G. Ordog,et al.  Serum digoxin levels and mortality in 5,100 patients. , 1987, Annals of emergency medicine.